🚀 Unlock the Future of CNS Drug Discovery with Pharmidex 🧠
August 28, 2024
At
Pharmidex, we're dedicated to advancing the frontier of Central Nervous System (CNS) drug discovery. With our deep expertise in
in vitro and
in vivo models, DMPK studies, and translational science, we provide end-to-end solutions that accelerate your CNS projects from concept to clinic.
🔬 Our CNS services include:
- In vitro assays for neurotoxicity, neuroprotection, and receptor binding.
- In vivo models for a wide range of CNS disorders including
neurodegeneration, psychiatric disorders, and pain. - DMPK studies with a focus on CNS penetration, blood-brain barrier
studies, and more. - Expert consultancy to optimize your CNS drug development strategy.
Partner with us to bring innovative therapies to patients faster. Let's collaborate and make breakthroughs in CNS research together!
🌐 Explore our CNS services:
https://www.pharmidex.com/CNS
#CNS #Neuroscience #DrugDiscovery #Pharmidex #LifeSciences #Neuropharmacology #DMPK #TranslationalResearch #Biotech #Pharma
We’re excited to share that Ash Alavijeh , our Head of Operations, will attend the Swiss Biotech Day 2025 on May 5–6 at the Congress Center Basel, Switzerland! 🔗 https://swissbiotechday.ch Ash looks forward to connecting with attendees to explore new collaborations and drive drug discovery and development forward. If you're in Basel, let's meet and discuss how we can advance the next wave of innovative therapies together.
We are pleased to announce that Martin Barrett , our Head of Business Development, will be attending the Making & Distributing Pharmaceuticals UK event on 29–30 April 2025 at the Coventry Building Society Arena! 🔗 ( https://lnkd.in/gd73pvE ) Martin would be delighted to meet with fellow attendees to discuss new collaboration opportunities and how we can work together to advance the development of innovative drug candidates. If you are attending, don’t miss the chance to connect with us and explore how we can drive pharmaceutical progress forward together!
We’re excited that Ash Alavijeh , our Head of Operations, will attend the Biotech Matchmaking Event on 29 April 2025 at the Old Divinity School, St John’s College, Cambridge. 🔗 (Biotech Matchmaking Event - The Milner Therapeutics Institute) Ash looks forward to meeting attendees, discussing new collaborations, and driving forward the development of innovative drug candidates. If you're attending, let’s connect and explore new opportunities together!
